We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WDS:NYSEWoodside Energy Group Limited Analysis

Data as of 2026-09-01 - not real-time

$23.28

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Woodside Energy Group Ltd is priced at $23.28 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 7.5%. RSI sits at 53.8, which reads as neutral, and MACD momentum is bearish. Watch $21.99 as support and $24.42 as the nearer resistance level.
Multiples put this in undervalued territory: 14.4 times earnings against the sector's 21.6. Revenue is growing at 13.0% on a 22.2% profit margin. The 4.98% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 32.4%, a beta of -0.28 and a maximum drawdown of 23.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top Market Events

Woodside Energy Group Ltd ASX: WDS Q2 2026: Revenue up 28%, growth projects on track, reliable operations, and guidance...Shares in Woodside Energy Group Ltd ASX: WDS are trading higher after rumours that the oil and gas major could be a...Woodside shares are grabbing headlines this week.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 20.37
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 14.4 versus sector average of 21.6
  • Trading above the 200-day average of 20.37

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 14.4 versus sector average of 21.6
  • Profit margin of 22.2% is healthy
  • Revenue growth of +13.0%

Key Metrics & Analysis

Financial Health

Revenue Growth13.00%
Profit Margin22.21%
P/E Ratio14.4
ROE7.68%
ROA2.83%
Debt/Equity32.76
P/B Ratio1.2
Op. Cash Flow$6.9B
Free Cash Flow$562.5M
Industry P/E21.6

Technical Analysis

TrendBullish
RSI53.8
Support$21.99
Resistance$24.42
MA 20$23.17
MA 50$21.80
MA 200$20.37
MACDBearish
VolumeStable
Fear & Greed Index93.27

Valuation

Fair Value$1.63
Target Price$22.73
Upside/Downside-2.38%
GradeUndervalued
TypeValue
Dividend Yield4.98%

Risk Assessment

Beta-0.28
Volatility32.43%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.